Glen Eagle Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3
Closed -$742 1143
2025
Q3
$742 Hold
3
﹤0.01% 1030
2025
Q2
$721 Hold
3
﹤0.01% 958
2025
Q1
$680 Hold
3
﹤0.01% 969
2024
Q4
$617 Hold
3
﹤0.01% 1015
2024
Q3
$728 Hold
3
﹤0.01% 1038
2024
Q2
$659 Hold
3
﹤0.01% 1052
2024
Q1
$674 Hold
3
﹤0.01% 1017
2023
Q4
$660 Sell
3
-6
-67% -$1.27K ﹤0.01% 958
2023
Q3
$1.98K Hold
9
﹤0.01% 865
2023
Q2
$2.02K Hold
9
﹤0.01% 875
2023
Q1
$1.72K Hold
9
﹤0.01% 874
2022
Q4
$1.66K Hold
9
﹤0.01% 918
2022
Q3
$1.5K Hold
9
﹤0.01% 917
2022
Q2
$1.85K Hold
9
﹤0.01% 836
2022
Q1
$2.18K Hold
9
﹤0.01% 795
2021
Q4
$2.19K Hold
9
﹤0.01% 796
2021
Q3
$1.84K Hold
9
﹤0.01% 927
2021
Q2
$1.86K Hold
9
﹤0.01% 924
2021
Q1
$1.71K Hold
9
﹤0.01% 894
2020
Q4
$1.71K Buy
+9
New +$1.68K ﹤0.01% 863

Other funds holding STE

Glen Eagle Advisors's STE Position: Q4 2025 in Review

Glen Eagle Advisors sold out of Steris (STE) in Q4 2025, closing a stake of 3 shares — an estimated $742 sold.

Glen Eagle Advisors first reported a position in STE in Q4 2020 and held it in 20 quarters. The position peaked at $2.19K in Q4 2021. 894 funds tracked by Wall St. Rank hold STE as of Q4 2025.

  • Glen Eagle Advisors reported no remaining Steris position as of Q4 2025 after selling out during the quarter.
  • Glen Eagle Advisors sold 3 Steris shares in Q4 2025, an estimated $742.
  • Glen Eagle Advisors first reported a position in Steris in Q4 2020 and held it in 20 quarters.
  • Glen Eagle Advisors's Steris position peaked at $2.19K in Q4 2021.
  • 894 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on Glen Eagle Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.